Lessons From Chernobyl Hampered By Fears Of Litigation

March 27, 1998

(Chernobyl and public health - The nuclear industry should fund an international foundation to learn from Chernobyl)

In an editorial in this week's BMJ, Baverstock suggests that those who benefit from the production of nuclear electricity should finance an independent international foundation to co-ordinate research and provide humanitarian aid to victims such as those affected by the Chernobyl accident.

The author reveals that despite initial scepticism within the scientific community that the effects of Chernobyl have caused a prevalence of thyroid cancers in children, the link is now very clear. He suggests that reluctance to believe that environmental sources of radiation could be strongly associated with serious disease is no coincidence, coming from countries where populations are more litigious (weapons testing in the atmosphere over Nevada in the early sixties appears to have left few parts of America unaffected by releases of Iodine-131, three or four times greater than those from Chernobyl).

Baverstock fears that if we continue in such a vein, the prospects of learning from the Chernobyl accident over the necessary time scale (the next 40 years for so) are bleak. Firstly, the former Soviet Union does not have the economic ability to conduct any epidemiological research within the affected region. Secondly, the initial scepticism and acrimonious debate in the international scientific community did little to encourage collaboration between agencies providing aid or conducting research. Finally, there is competition between scientists to find a 'marker' to clinically prove a link between radiation an certain caners, which, says the author, is wholly unproductive.

The author concludes by saying that for research results to be meaningful, independence from vested interests needs to be guaranteed. But he fears that the compensation issue in America and within the nuclear industry is potentially so large, significant sums could be spent to frustrate legitimate research in the hope of avoiding much larger sums in compensation.

Contact:

Keith Baverstock, WHO European Centre for Environment and Health, Rome, Italy keith.baverstock@stuk.fi
-end-


BMJ

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.